Biomarker Discovery
Cross-source consensus on Biomarker Discovery from 1 sources and 4 claims.
1 sources · 4 claims
Uses
How it works
Benefits
Risks & contraindications
Highlighted claims
- High-dimensional genomic classification makes biomarker discovery vulnerable to unstable feature selection because many feature subsets can perform similarly. — StackFeat RL: Reinforcement Learning over Iterative Dual Criterion Feature Selection for Stable Biomarker Discovery
- Clinical follow-up requires compact and reproducible biomarker panels, so predictive accuracy alone is not sufficient. — StackFeat RL: Reinforcement Learning over Iterative Dual Criterion Feature Selection for Stable Biomarker Discovery
- Dual-criterion accumulation is framed as central because it requires both directional coefficient consistency and recurring selection. — StackFeat RL: Reinforcement Learning over Iterative Dual Criterion Feature Selection for Stable Biomarker Discovery
- The main practical implication is that iterative dual-criterion selection can be made feasible for high-dimensional biomarker discovery while keeping panels compact. — StackFeat RL: Reinforcement Learning over Iterative Dual Criterion Feature Selection for Stable Biomarker Discovery